mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.081 |
0.07 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.08 |
0.07 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.07 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.08 |